Skip Nav Destination
Issues
1 February 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editorial
The Biology Behind
Review
Report from the Food and Drug Administration
Pemetrexed in Malignant Pleural Mesothelioma
Maitreyee Hazarika; Robert M. White, Jr.; Brian P. Booth; Yong-Cheng Wang; Doo Y. Lee Ham; Cheng Yi Liang; Atiqur Rahman; Jogarao V.S. Gobburu; Ning Li; Rajeshwari Sridhara; David E. Morse; Richard Lostritto; Patricia Garvey; John R. Johnson; Richard Pazdur
Human Cancer Biology
Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer
Hiroyuki Hariu; Yoshihiko Hirohashi; Toshihiko Torigoe; Hiroko Asanuma; Midori Hariu; Yasuaki Tamura; Katsuyuki Aketa; Chika Nabeta; Katsuya Nakanishi; Kenjiro Kamiguchi; Yoshinori Mano; Hiroshi Kitamura; Junichi Kobayashi; Tomohide Tsukahara; Noriharu Shijubo; Noriyuki Sato
Aberrant Methylation and Silencing of the BNIP3 Gene in Colorectal and Gastric Cancer
Masafumi Murai; Minoru Toyota; Hiromu Suzuki; Ayumi Satoh; Yasushi Sasaki; Kimishige Akino; Masako Ueno; Fumihiko Takahashi; Masanobu Kusano; Hiroaki Mita; Kazuyoshi Yanagihara; Takao Endo; Yuji Hinoda; Takashi Tokino; Kohzoh Imai
Increased Heparanase Expression Is Caused by Promoter Hypomethylation and Up-Regulation of Transcriptional Factor Early Growth Response-1 in Human Prostate Cancer
Tatsuya Ogishima; Hiroaki Shiina; Julia E. Breault; Laura Tabatabai; William W. Bassett; Hideki Enokida; Long-Cheng Li; Toshifumi Kawakami; Shinji Urakami; Leopoldo A. Ribeiro-Filho; Masaharu Terashima; Makoto Fujime; Mikio Igawa; Rajvir Dahiya
Coexpression of Erythropoietin and Erythropoietin Receptor in Von Hippel-Lindau Disease–Associated Renal Cysts and Renal Cell Carcinoma
Youn-Soo Lee; Alexander O. Vortmeyer; Irina A. Lubensky; Timothy W.A. Vogel; Barbara Ikejiri; Sophie Ferlicot; Gérard Benoît; Sophie Giraud; Edward H. Oldfield; W. Marston Linehan; Bin T. Teh; Stéphane Richard; Zhengping Zhuang
Imaging, Diagnosis, Prognosis
Expression of the FOXP1 Transcription Factor Is Strongly Associated with Inferior Survival in Patients with Diffuse Large B-Cell Lymphoma
Alison H. Banham; Joseph M. Connors; Philip J. Brown; Jacqueline L. Cordell; German Ott; Gayatri Sreenivasan; Pedro Farinha; Douglas E. Horsman; Randy D. Gascoyne
A Predictor Based on the Somatic Genomic Changes of the BRCA1/BRCA2 Breast Cancer Tumors Identifies the Non-BRCA1/BRCA2 Tumors with BRCA1 Promoter Hypermethylation
Sara Alvarez; Ramon Diaz-Uriarte; Ana Osorio; Alicia Barroso; Lorenzo Melchor; Maria Fe Paz; Emiliano Honrado; Raquel Rodríguez; Miguel Urioste; Laura Valle; Orland Díez; Juan Cruz Cigudosa; Joaquin Dopazo; Manel Esteller; Javier Benitez
The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers
Masaki Tokumo; Shinichi Toyooka; Katsuyuki Kiura; Hisayuki Shigematsu; Kunitoshi Tomii; Motoi Aoe; Kouichi Ichimura; Toshihide Tsuda; Masaaki Yano; Kazunori Tsukuda; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto; Hiroshi Date; Adi F. Gazdar; Nobuyoshi Shimizu
Transcriptional Profiles in Peripheral Blood Mononuclear Cells Prognostic of Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma
Michael E. Burczynski; Natalie C. Twine; Gary Dukart; Bonnie Marshall; Manuel Hidalgo; Walter M. Stadler; Theodore Logan; Janice Dutcher; Gary Hudes; William L. Trepicchio; Andrew Strahs; Fred Immermann; Donna K. Slonim; Andrew J. Dorner
Early Lymphocyte Recovery Predicts Superior Survival after Autologous Hematopoietic Stem Cell Transplantation for Patients with Primary Systemic Amyloidosis
Luis F. Porrata; Morie A. Gertz; Mark R. Litzow; Martha Q. Lacy; Angela Dispenzieri; David J. Inwards; Stephen M. Ansell; Ivanna N.M. Micallef; Dennis A. Gastineau; Michele Elliott; William J. Hogan; Suzanne R. Hayman; Ayalew Tefferi; Svetomir N. Markovic
Cancer Therapy: Clinical
A Phase I Trial and Pharmacokinetic Study of Tipifarnib, a Farnesyltransferase Inhibitor, and Tamoxifen in Metastatic Breast Cancer
Peter F. Lebowitz; Jennifer Eng-Wong; Brigitte C. Widemann; Frank M. Balis; Nalini Jayaprakash; Catherine Chow; Geoff Clark; Susan B. Gantz; David Venzon; JoAnne Zujewski
Cancer Therapy: Preclinical
Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor-2 and Epidermal Growth Factor Receptor Small Molecule Tyrosine Kinase Inhibitor, in Combination with SC-236, a Cyclooxygenase-2 Inhibitor
Concetta Tuccillo; Marco Romano; Teresa Troiani; Erika Martinelli; Floriana Morgillo; Ferdinando De Vita; Roberto Bianco; Gabriella Fontanini; Raffaele A. Bianco; Giampaolo Tortora; Fortunato Ciardiello
Combination of IFN-α and 5-Fluorouracil Induces Apoptosis through IFN-α/β Receptor in Human Hepatocellular Carcinoma Cells
Motoi Kondo; Hiroaki Nagano; Hiroshi Wada; Bazarragchaa Damdinsuren; Hirofumi Yamamoto; Nobuaki Hiraoka; Hidetoshi Eguchi; Atsushi Miyamoto; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
A Fiber-Modified, Secretory Leukoprotease Inhibitor Promoter-Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer
Daniel T. Rein; Martina Breidenbach; Tyler O. Kirby; Tie Han; Gene P. Siegal; Gerd J. Bauerschmitz; Minghui Wang; Dirk M. Nettelbeck; Yuko Tsuruta; Masato Yamamoto; Peter Dall; Akseli Hemminki; David T. Curiel
Cancer Prevention
Letters to the Editor
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.